[VIVO] YoY Quarter Result on 30-Jun-2017 [#Q3]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
09-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q3]
Profit Trend
QoQ- -97.42%
YoY- -97.26%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 84,797 48,440 51,737 50,140 50,665 48,204 47,212 10.24%
PBT 34,873 6,478 8,620 3,946 13,401 14,305 12,880 18.04%
Tax 7,366 1,399 1,795 3,706 4,647 5,203 4,045 10.49%
NP 27,507 5,079 6,825 240 8,754 9,102 8,835 20.81%
Tax Rate -21.12% -21.60% -20.82% -93.92% -34.68% -36.37% -31.41% -
Total Cost 57,290 43,361 44,912 49,900 41,911 39,102 38,377 6.89%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 32.44 10.49 13.19 0.48 17.28 18.88 18.71 9.59%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 0.64 0.12 0.16 0.01 0.21 0.22 0.21 20.38%
EPS Diluted 0.64 0.12 0.16 0.01 0.21 0.22 0.21 20.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.